US03815U3005 - Common Stock - Premarket: 3.42 +0.09 (+2.7%)
NASDAQ:APDN (8/16/2022, 7:16:35 PM)-0.1 (-2.92%)
GICS Sector | Health Care | ||
GICS Industry | Life Sciences Tools & Services |
Valuation | Growth | ||
Profitability | Health | ||
Dividend |
Earnings (Last) | 08-11 2022-08-11/amc | Earnings (Next) | 12-07 2022-12-07 |
Ins Owners | N/A | Inst Owners | 13.29% |
Market Cap | 29.91M | Shares | 8.98M |
PE | N/A | Fwd PE | N/A |
Dividend Yield | N/A | Analysts | 82.22 |
IPO | 08-24 2001-08-24 |
Find more stocks on Nasdaq
Find more stocks on the USA
Find competitors from the same sector on the USA
Find competitors from the same industry on the USA
Find stocks with similar TA and Setup ratings on the USA
Find stocks with similar Fundamental rating on the USA
Find more growth stocks the USA
Find the competitors with the best technical ratings on the USA
Find the competitors with the best technical and setup ratings on the USA
Find the competitors with the best fundamentals on the USA
Find the competitors with the best valuation on the USA
Find the competitors with the best dividend on the USA
Find the competitors with the best analyst ratings on the USA
Applied DNA Sciences, Inc. engages in the developing and marketing DNA-based technology solutions utilizing LinearDNA, large-scale polymerase chain reaction (PCR) based manufacturing platform. The company is headquartered in Stony Brook, New York and currently employs 78 full-time employees. The company went IPO on 2001-08-24. The firm is utilizing its LinearDNA large-scale polymerase chain reaction (PCR) based manufacturing platform. The Company’s proprietary platform produces large quantities of DNA for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets and for supply chain security, anti-counterfeiting and anti-theft technology purposes. Applied DNA also develops PCR-based molecular in vitro diagnostics for covid-19. In addition, under its wholly owned subsidiary, Applied DNA Clinical Labs, LLC, the Company is offering a high-throughput turnkey solution for population-scale Covid-19 testing marketed as safeCircle. safeCircle utilizes the Company’s Covid-19 Diagnostic Tests and is designed to look for infection within defined populations or communities utilizing high throughput testing methodologies.
APPLIED DNA SCIENCES INC
50 Health Sciences Drive
Stony Brook NEW YORK 11790
P: 16312408800.0
CEO: James A. Hayward
Employees: 78
Website: http://www.adnas.com/
Let's have a look at the stocks with an unusual volume in today's session.
Here you can normally see the latest stock twits on APDN, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: